Spectrum of Immune Checkpoint Inhibitor Anemias: Results From a Single Center, Early-Phase Clinical Trials Case Series Experience

Immune checkpoint inhibitor anemias (ICI-A) are a rare entity which can be potentially life-threatening without prompt identification. The goal of the study is to characterize the presentation, evaluation, and outcomes of ICI therapy in early phase clinical trial setting to guide future research and...

Descripción completa

Detalles Bibliográficos
Autores principales: Nelson, Blessie Elizabeth, Ejezie, Chinenye Lynette, Stephen, Bettzy A., Nardo, Mirella, Campbell, Erick, Gong, Jing, Hong, David S., Fu, Siqing, Yap, Timothy A., Murphy, Mariela Blum, Piha-Paul, Sarina, Daver, Naval G., Rojas-Hernandez, Cristhiam M., Naing, Aung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9275440/
https://www.ncbi.nlm.nih.gov/pubmed/35837373
http://dx.doi.org/10.14740/jh1006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9275440/
https://www.ncbi.nlm.nih.gov/pubmed/35837373
http://dx.doi.org/10.14740/jh1006

Ejemplares similares